1. Home
  2. MBIO vs PMAX Comparison

MBIO vs PMAX Comparison

Compare MBIO & PMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBIO
  • PMAX
  • Stock Information
  • Founded
  • MBIO 2015
  • PMAX 2019
  • Country
  • MBIO United States
  • PMAX Hong Kong
  • Employees
  • MBIO N/A
  • PMAX N/A
  • Industry
  • MBIO Biotechnology: Pharmaceutical Preparations
  • PMAX
  • Sector
  • MBIO Health Care
  • PMAX
  • Exchange
  • MBIO Nasdaq
  • PMAX Nasdaq
  • Market Cap
  • MBIO 4.7M
  • PMAX 5.3M
  • IPO Year
  • MBIO N/A
  • PMAX 2024
  • Fundamental
  • Price
  • MBIO $1.22
  • PMAX $1.98
  • Analyst Decision
  • MBIO
  • PMAX
  • Analyst Count
  • MBIO 0
  • PMAX 0
  • Target Price
  • MBIO N/A
  • PMAX N/A
  • AVG Volume (30 Days)
  • MBIO 81.7K
  • PMAX 40.7K
  • Earning Date
  • MBIO 11-07-2025
  • PMAX 09-23-2025
  • Dividend Yield
  • MBIO N/A
  • PMAX N/A
  • EPS Growth
  • MBIO N/A
  • PMAX N/A
  • EPS
  • MBIO N/A
  • PMAX N/A
  • Revenue
  • MBIO N/A
  • PMAX $4,799,100.00
  • Revenue This Year
  • MBIO N/A
  • PMAX N/A
  • Revenue Next Year
  • MBIO N/A
  • PMAX N/A
  • P/E Ratio
  • MBIO N/A
  • PMAX N/A
  • Revenue Growth
  • MBIO N/A
  • PMAX N/A
  • 52 Week Low
  • MBIO $0.89
  • PMAX $1.83
  • 52 Week High
  • MBIO $21.95
  • PMAX $27.44
  • Technical
  • Relative Strength Index (RSI)
  • MBIO 35.63
  • PMAX 41.87
  • Support Level
  • MBIO $1.14
  • PMAX $2.42
  • Resistance Level
  • MBIO $1.27
  • PMAX $2.36
  • Average True Range (ATR)
  • MBIO 0.09
  • PMAX 0.17
  • MACD
  • MBIO -0.01
  • PMAX -0.11
  • Stochastic Oscillator
  • MBIO 20.23
  • PMAX 7.61

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About PMAX Powell Max Limited

Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.

Share on Social Networks: